Direct Healthcare Cost of Ischemic Stroke Management in Morocco.
cost-of-illness
direct medical cost
ischemic stroke
morocco
neurology
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
accepted:
15
07
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Strokes are a group of heterogeneous conditions that can cause lasting brain damage, long-term disability, or even death. In Morocco, the management of this disease generates important expenses and increases the financial burden on health care. In order to rationalize the expenses and to direct the budgetary policy in healthcare, we aimed to estimate the cost of ischemic stroke (IS) management in Morocco through this study. A cost-of-illness study was conducted between March 2018 and March 2019 at the neurology department of the Hassan II University Hospital, Fez. We included all patients who were admitted, during this period, to the department for IS. The collected data included sociodemographic information, and all details regarding the patient's medical management (diagnosis, treatment, etc.). The cost was estimated using a "bottom-up micro-costing" approach with a societal perspective. A total of 267 individuals were included in this study with a female predominance (56.6%); the mean age was 66.93 ± 14.83 years. The total cost of ischemic stroke management per patient per year was estimated at $3674.32 ± 1340.81, with a high share related to hospitalization at $1415.06 ± 1015.53. A statistically significant association was found between total cost and age (p=0.014), National Institutes of Health Stroke Scale (NIHSS) score (p≤0.001), and length of hospitalization (p≤0.001); however, no association was found with other factors (sex, complication, Rankin score, etc.). Ischemic strokes are relatively frequent in Morocco. Their management generates an important cost, which is influenced by several factors such as severity of the disease and the duration of hospitalization. This cost can be decreased by rationalizing the expenses and acting on various risk factors of ischemic strokes.
Sections du résumé
BACKGROUND
BACKGROUND
Strokes are a group of heterogeneous conditions that can cause lasting brain damage, long-term disability, or even death. In Morocco, the management of this disease generates important expenses and increases the financial burden on health care. In order to rationalize the expenses and to direct the budgetary policy in healthcare, we aimed to estimate the cost of ischemic stroke (IS) management in Morocco through this study.
METHODS
METHODS
A cost-of-illness study was conducted between March 2018 and March 2019 at the neurology department of the Hassan II University Hospital, Fez. We included all patients who were admitted, during this period, to the department for IS. The collected data included sociodemographic information, and all details regarding the patient's medical management (diagnosis, treatment, etc.). The cost was estimated using a "bottom-up micro-costing" approach with a societal perspective.
RESULTS
RESULTS
A total of 267 individuals were included in this study with a female predominance (56.6%); the mean age was 66.93 ± 14.83 years. The total cost of ischemic stroke management per patient per year was estimated at $3674.32 ± 1340.81, with a high share related to hospitalization at $1415.06 ± 1015.53. A statistically significant association was found between total cost and age (p=0.014), National Institutes of Health Stroke Scale (NIHSS) score (p≤0.001), and length of hospitalization (p≤0.001); however, no association was found with other factors (sex, complication, Rankin score, etc.).
CONCLUSION
CONCLUSIONS
Ischemic strokes are relatively frequent in Morocco. Their management generates an important cost, which is influenced by several factors such as severity of the disease and the duration of hospitalization. This cost can be decreased by rationalizing the expenses and acting on various risk factors of ischemic strokes.
Identifiants
pubmed: 37602017
doi: 10.7759/cureus.42180
pmc: PMC10439518
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e42180Informations de copyright
Copyright © 2023, Omari et al.
Déclaration de conflit d'intérêts
The authors have declared financial relationships, which are detailed in the next section.
Références
Acta Neurol Scand. 2009 Apr;119(4):246-53
pubmed: 18771525
Lancet Neurol. 2007 Feb;6(2):182-7
pubmed: 17239805
Med Sci (Paris). 2009 Aug-Sep;25(8-9):727-32
pubmed: 19765387
J Med Assoc Thai. 2012 Oct;95(10):1266-77
pubmed: 23193739
J Pak Med Assoc. 2003 Nov;53(11):552-5
pubmed: 14738264
Int J Environ Res Public Health. 2017 Apr 19;14(4):
pubmed: 28422077
Med Trop (Mars). 2005 Nov;65(5):458-64
pubmed: 16465816
Crit Care Med. 2020 Nov;48(11):1654-1663
pubmed: 32947473
Neurology. 2015 Jun 2;84(22):2208-15
pubmed: 25934858
PLoS One. 2010 Sep 28;5(9):
pubmed: 20927384
PLoS One. 2014 Feb 28;9(2):e89271
pubmed: 24586649
Sci Rep. 2022 Feb 17;12(1):2700
pubmed: 35177688
Health Policy. 2006 Jun;77(1):51-63
pubmed: 16139925
BMC Neurol. 2019 Dec 30;19(1):349
pubmed: 31888526
Neurol Clin Pract. 2014 Oct;4(5):427-434
pubmed: 29443219
Brain Sci. 2021 May 24;11(6):
pubmed: 34073732
Clin Neurol Neurosurg. 2011 Feb;113(2):111-4
pubmed: 21036465
Lancet. 2006 May 27;367(9524):1747-57
pubmed: 16731270
J Neurol Sci. 2009 Sep 15;284(1-2):18-23
pubmed: 19428027
Med J Malaysia. 2012 Oct;67(5):473-7
pubmed: 23770861
Glob J Health Sci. 2012 Aug 15;4(6):17-22
pubmed: 23121738